1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Montelukast Drug Revenue
1.4 Market Analysis by Type
1.4.1 Global Montelukast Drug Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Tablet
1.4.3 Chewable tablet
1.4.4 Oral Granules
1.5 Market by Application
1.5.1 Global Montelukast Drug Market Share by Application: 2021-2026
1.5.2 Hospital
1.5.3 Drug store
1.5.4 Others
1.6 Study Objectives
1.7 Years Considered
1.8 Overview of Global Montelukast Drug Market
1.8.1 Global Montelukast Drug Market Status and Outlook (2015-2026)
1.8.2 North America
1.8.3 East Asia
1.8.4 Europe
1.8.5 South Asia
1.8.6 Southeast Asia
1.8.7 Middle East
1.8.8 Africa
1.8.9 Oceania
1.8.10 South America
1.8.11 Rest of the World
2 Market Competition by Manufacturers
2.1 Global Montelukast Drug Production Capacity Market Share by Manufacturers (2015-2020)
2.2 Global Montelukast Drug Revenue Market Share by Manufacturers (2015-2020)
2.3 Global Montelukast Drug Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Montelukast Drug Production Sites, Area Served, Product Type
3 Sales by Region
3.1 Global Montelukast Drug Sales Volume Market Share by Region (2015-2020)
3.2 Global Montelukast Drug Sales Revenue Market Share by Region (2015-2020)
3.3 North America Montelukast Drug Sales Volume
3.3.1 North America Montelukast Drug Sales Volume Growth Rate (2015-2020)
3.3.2 North America Montelukast Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.4 East Asia Montelukast Drug Sales Volume
3.4.1 East Asia Montelukast Drug Sales Volume Growth Rate (2015-2020)
3.4.2 East Asia Montelukast Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.5 Europe Montelukast Drug Sales Volume (2015-2020)
3.5.1 Europe Montelukast Drug Sales Volume Growth Rate (2015-2020)
3.5.2 Europe Montelukast Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.6 South Asia Montelukast Drug Sales Volume (2015-2020)
3.6.1 South Asia Montelukast Drug Sales Volume Growth Rate (2015-2020)
3.6.2 South Asia Montelukast Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.7 Southeast Asia Montelukast Drug Sales Volume (2015-2020)
3.7.1 Southeast Asia Montelukast Drug Sales Volume Growth Rate (2015-2020)
3.7.2 Southeast Asia Montelukast Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.8 Middle East Montelukast Drug Sales Volume (2015-2020)
3.8.1 Middle East Montelukast Drug Sales Volume Growth Rate (2015-2020)
3.8.2 Middle East Montelukast Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.9 Africa Montelukast Drug Sales Volume (2015-2020)
3.9.1 Africa Montelukast Drug Sales Volume Growth Rate (2015-2020)
3.9.2 Africa Montelukast Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.10 Oceania Montelukast Drug Sales Volume (2015-2020)
3.10.1 Oceania Montelukast Drug Sales Volume Growth Rate (2015-2020)
3.10.2 Oceania Montelukast Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.11 South America Montelukast Drug Sales Volume (2015-2020)
3.11.1 South America Montelukast Drug Sales Volume Growth Rate (2015-2020)
3.11.2 South America Montelukast Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
3.12 Rest of the World Montelukast Drug Sales Volume (2015-2020)
3.12.1 Rest of the World Montelukast Drug Sales Volume Growth Rate (2015-2020)
3.12.2 Rest of the World Montelukast Drug Sales Volume Capacity, Revenue, Price and Gross Margin (2015-2020)
4 North America
4.1 North America Montelukast Drug Consumption by Countries
4.2 United States
4.3 Canada
4.4 Mexico
5 East Asia
5.1 East Asia Montelukast Drug Consumption by Countries
5.2 China
5.3 Japan
5.4 South Korea
6 Europe
6.1 Europe Montelukast Drug Consumption by Countries
6.2 Germany
6.3 United Kingdom
6.4 France
6.5 Italy
6.6 Russia
6.7 Spain
6.8 Netherlands
6.9 Switzerland
6.10 Poland
7 South Asia
7.1 South Asia Montelukast Drug Consumption by Countries
7.2 India
7.3 Pakistan
7.4 Bangladesh
8 Southeast Asia
8.1 Southeast Asia Montelukast Drug Consumption by Countries
8.2 Indonesia
8.3 Thailand
8.4 Singapore
8.5 Malaysia
8.6 Philippines
8.7 Vietnam
8.8 Myanmar
9 Middle East
9.1 Middle East Montelukast Drug Consumption by Countries
9.2 Turkey
9.3 Saudi Arabia
9.4 Iran
9.5 United Arab Emirates
9.6 Israel
9.7 Iraq
9.8 Qatar
9.9 Kuwait
9.10 Oman
10 Africa
10.1 Africa Montelukast Drug Consumption by Countries
10.2 Nigeria
10.3 South Africa
10.4 Egypt
10.5 Algeria
10.6 Morocco
11 Oceania
11.1 Oceania Montelukast Drug Consumption by Countries
11.2 Australia
11.3 New Zealand
12 South America
12.1 South America Montelukast Drug Consumption by Countries
12.2 Brazil
12.3 Argentina
12.4 Columbia
12.5 Chile
12.6 Venezuela
12.7 Peru
12.8 Puerto Rico
12.9 Ecuador
13 Rest of the World
13.1 Rest of the World Montelukast Drug Consumption by Countries
13.2 Kazakhstan
14 Sales Volume, Sales Revenue, Sales Price Trend by Type
14.1 Global Montelukast Drug Sales Volume Market Share by Type (2015-2020)
14.2 Global Montelukast Drug Sales Revenue Market Share by Type (2015-2020)
14.3 Global Montelukast Drug Sales Price by Type (2015-2020)
15 Consumption Analysis by Application
15.1 Global Montelukast Drug Consumption Volume by Application (2015-2020)
15.2 Global Montelukast Drug Consumption Value by Application (2015-2020)
16 Company Profiles and Key Figures in Montelukast Drug Business
16.1 Merck & Co.
16.1.1 Merck & Co. Company Profile
16.1.2 Merck & Co. Montelukast Drug Product Specification
16.1.3 Merck & Co. Montelukast Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.2 Lannett Company
16.2.1 Lannett Company Company Profile
16.2.2 Lannett Company Montelukast Drug Product Specification
16.2.3 Lannett Company Montelukast Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.3 Glenmark Pharmaceuticals
16.3.1 Glenmark Pharmaceuticals Company Profile
16.3.2 Glenmark Pharmaceuticals Montelukast Drug Product Specification
16.3.3 Glenmark Pharmaceuticals Montelukast Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.4 Teva
16.4.1 Teva Company Profile
16.4.2 Teva Montelukast Drug Product Specification
16.4.3 Teva Montelukast Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.5 Torrent Pharmaceuticals
16.5.1 Torrent Pharmaceuticals Company Profile
16.5.2 Torrent Pharmaceuticals Montelukast Drug Product Specification
16.5.3 Torrent Pharmaceuticals Montelukast Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.6 Mylan
16.6.1 Mylan Company Profile
16.6.2 Mylan Montelukast Drug Product Specification
16.6.3 Mylan Montelukast Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.7 Dr. Reddys Laboratories
16.7.1 Dr. Reddys Laboratories Company Profile
16.7.2 Dr. Reddys Laboratories Montelukast Drug Product Specification
16.7.3 Dr. Reddys Laboratories Montelukast Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.8 Sandoz
16.8.1 Sandoz Company Profile
16.8.2 Sandoz Montelukast Drug Product Specification
16.8.3 Sandoz Montelukast Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.9 Hikma Group
16.9.1 Hikma Group Company Profile
16.9.2 Hikma Group Montelukast Drug Product Specification
16.9.3 Hikma Group Montelukast Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.10 Apotex
16.10.1 Apotex Company Profile
16.10.2 Apotex Montelukast Drug Product Specification
16.10.3 Apotex Montelukast Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.11 Ajanta Pharma
16.11.1 Ajanta Pharma Company Profile
16.11.2 Ajanta Pharma Montelukast Drug Product Specification
16.11.3 Ajanta Pharma Montelukast Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.12 Unichem Laboratories
16.12.1 Unichem Laboratories Company Profile
16.12.2 Unichem Laboratories Montelukast Drug Product Specification
16.12.3 Unichem Laboratories Montelukast Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.13 Aurobindo Pharma
16.13.1 Aurobindo Pharma Company Profile
16.13.2 Aurobindo Pharma Montelukast Drug Product Specification
16.13.3 Aurobindo Pharma Montelukast Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.14 Shanghai Anbison Lab
16.14.1 Shanghai Anbison Lab Company Profile
16.14.2 Shanghai Anbison Lab Montelukast Drug Product Specification
16.14.3 Shanghai Anbison Lab Montelukast Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.15 MACLEODS
16.15.1 MACLEODS Company Profile
16.15.2 MACLEODS Montelukast Drug Product Specification
16.15.3 MACLEODS Montelukast Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.16 Unimark
16.16.1 Unimark Company Profile
16.16.2 Unimark Montelukast Drug Product Specification
16.16.3 Unimark Montelukast Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.17 Accord Healthcare
16.17.1 Accord Healthcare Company Profile
16.17.2 Accord Healthcare Montelukast Drug Product Specification
16.17.3 Accord Healthcare Montelukast Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.18 Amneal Pharmaceuticals
16.18.1 Amneal Pharmaceuticals Company Profile
16.18.2 Amneal Pharmaceuticals Montelukast Drug Product Specification
16.18.3 Amneal Pharmaceuticals Montelukast Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.19 Jubilant Pharma
16.19.1 Jubilant Pharma Company Profile
16.19.2 Jubilant Pharma Montelukast Drug Product Specification
16.19.3 Jubilant Pharma Montelukast Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.20 Hetero
16.20.1 Hetero Company Profile
16.20.2 Hetero Montelukast Drug Product Specification
16.20.3 Hetero Montelukast Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.21 Perrigo
16.21.1 Perrigo Company Profile
16.21.2 Perrigo Montelukast Drug Product Specification
16.21.3 Perrigo Montelukast Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.22 Cipla
16.22.1 Cipla Company Profile
16.22.2 Cipla Montelukast Drug Product Specification
16.22.3 Cipla Montelukast Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
16.23 CSPC Ouyi Pharmaceutical
16.23.1 CSPC Ouyi Pharmaceutical Company Profile
16.23.2 CSPC Ouyi Pharmaceutical Montelukast Drug Product Specification
16.23.3 CSPC Ouyi Pharmaceutical Montelukast Drug Production Capacity, Revenue, Price and Gross Margin (2015-2020)
17 Montelukast Drug Manufacturing Cost Analysis
17.1 Montelukast Drug Key Raw Materials Analysis
17.1.1 Key Raw Materials
17.2 Proportion of Manufacturing Cost Structure
17.3 Manufacturing Process Analysis of Montelukast Drug
17.4 Montelukast Drug Industrial Chain Analysis
18 Marketing Channel, Distributors and Customers
18.1 Marketing Channel
18.2 Montelukast Drug Distributors List
18.3 Montelukast Drug Customers
19 Market Dynamics
19.1 Market Trends
19.2 Opportunities and Drivers
19.3 Challenges
19.4 Porter's Five Forces Analysis
20 Production and Supply Forecast
20.1 Global Forecasted Production of Montelukast Drug (2021-2026)
20.2 Global Forecasted Revenue of Montelukast Drug (2021-2026)
20.3 Global Forecasted Price of Montelukast Drug (2015-2026)
20.4 Global Forecasted Production of Montelukast Drug by Region (2021-2026)
20.4.1 North America Montelukast Drug Production, Revenue Forecast (2021-2026)
20.4.2 East Asia Montelukast Drug Production, Revenue Forecast (2021-2026)
20.4.3 Europe Montelukast Drug Production, Revenue Forecast (2021-2026)
20.4.4 South Asia Montelukast Drug Production, Revenue Forecast (2021-2026)
20.4.5 Southeast Asia Montelukast Drug Production, Revenue Forecast (2021-2026)
20.4.6 Middle East Montelukast Drug Production, Revenue Forecast (2021-2026)
20.4.7 Africa Montelukast Drug Production, Revenue Forecast (2021-2026)
20.4.8 Oceania Montelukast Drug Production, Revenue Forecast (2021-2026)
20.4.9 South America Montelukast Drug Production, Revenue Forecast (2021-2026)
20.4.10 Rest of the World Montelukast Drug Production, Revenue Forecast (2021-2026)
20.5 Forecast by Type and by Application (2021-2026)
20.5.1 Global Sales Volume, Sales Revenue and Sales Price Forecast by Type (2021-2026)
20.5.2 Global Forecasted Consumption of Montelukast Drug by Application (2021-2026)
21 Consumption and Demand Forecast
21.1 North America Forecasted Consumption of Montelukast Drug by Country
21.2 East Asia Market Forecasted Consumption of Montelukast Drug by Country
21.3 Europe Market Forecasted Consumption of Montelukast Drug by Countriy
21.4 South Asia Forecasted Consumption of Montelukast Drug by Country
21.5 Southeast Asia Forecasted Consumption of Montelukast Drug by Country
21.6 Middle East Forecasted Consumption of Montelukast Drug by Country
21.7 Africa Forecasted Consumption of Montelukast Drug by Country
21.8 Oceania Forecasted Consumption of Montelukast Drug by Country
21.9 South America Forecasted Consumption of Montelukast Drug by Country
21.10 Rest of the world Forecasted Consumption of Montelukast Drug by Country
22 Research Findings and Conclusion
23 Methodology and Data Source
23.1 Methodology/Research Approach
23.1.1 Research Programs/Design
23.1.2 Market Size Estimation
23.1.3 Market Breakdown and Data Triangulation
23.2 Data Source
23.2.1 Secondary Sources
23.2.2 Primary Sources
23.3 Disclaimer